Repurposing drugs for diseases associated with podocyte dysfunction
Author:
Funder
National Institutes of Health
U.S. Department of Defense
NIDDK
CDMRP
Publisher
Elsevier BV
Subject
Nephrology
Reference40 articles.
1. The next generation of therapeutics for chronic kidney disease;Breyer;Nat Rev Drug Discov,2016
2. The key role of NLRP3 and STING in APOL1-associated podocytopathy;Wu;J Clin Invest,2021
3. Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease;Shahzad;Kidney Int,2022
4. Podocyte activation of NLRP3 inflammasomes contributes to the development of proteinuria in lupus nephritis;Fu;Arthritis Rheumatol,2017
5. Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients;Lucafo;Clin Transl Sci,2021
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of glomerular deposition of IgM and C3 in patients with podocytopathies;Annals of Diagnostic Pathology;2024-06
2. Big Data-Enabled Repurposing of Clopidogrel for Focal Segmental Glomerulosclerosis Using Network Biology;Drug Repurposing;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3